Literature DB >> 8168921

Regulation of major histocompatibility complex class II expression by Pasteurella haemolytica leukotoxin.

H P Hughes1, M Campos, L McDougall, T K Beskorwayne, A A Potter, L A Babiuk.   

Abstract

Many properties have been associated with Pasteurella haemolytica leukotoxin and other repeat-in-toxin toxins, including their cytotoxic activity on various cells of the lymphoid and nonlymphoid systems as well as their ability to modulate the immunological activity of lymphocytes and monocytes. In this study, we assessed the ability of P. haemolytica leukotoxin to affect the expression major histocompatibility complex (MHC) class II molecules on bovine peripheral monocytes. Peripheral blood mononuclear cells were isolated from P. haemolytica leukotoxin-seronegative calves and incubated with various concentrations of authentic leukotoxin as well as the recombinant lktA gene product (LktA). Expression of MHC class II antigen on cells was evaluated by flow cytometric methods. The results indicated that both a crude, authentic leukotoxin preparation and LktA were able to affect MHC class II expression by inducing a marked downregulation of MHC class II expression on bovine monocytes. However, when cells were activated with gamma interferon (IFN-gamma), LktA and Lkt had little or no detectable effect. By using a cell line which expresses MHC class II only after activation by INF-gamma, we were able to confirm the observation that LktA had no effect on the expression of MHC class II after IFN-gamma treatment. Leukotoxin affected the functional capacity of monocytes to present antigen, as demonstrated by the ability of LktA or authentic leukotoxin to totally inhibit a mixed lymphocyte culture from MHC-mismatched calves. Thus, leukotoxin was able to downregulate constitutive expression of MHC class II expression, and we propose that this is a novel way in which this molecule can affect the immune function of monocytes, playing an important role in bacterial pathogenesis and survival of organisms at the infection site.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8168921      PMCID: PMC186365          DOI: 10.1128/iai.62.5.1609-1615.1994

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  25 in total

1.  Oxidative killing of intracellular parasites mediated by macrophages.

Authors:  H P Hughes
Journal:  Parasitol Today       Date:  1988-12

2.  Alveolar macrophage and neutrophil interactions in Pasteurella haemolytica-induced endothelial cell injury.

Authors:  S A Sharma; T W Olchowy; M A Breider
Journal:  J Infect Dis       Date:  1992-04       Impact factor: 5.226

3.  Purification and biological characterizationof endotoxin fractions from Pasteruella haemolytica.

Authors:  R L Rimsay; J E Coyle-Dennis; L H Lauerman; P G Squire
Journal:  Am J Vet Res       Date:  1981-12       Impact factor: 1.156

4.  Effects of Pasteurella haemolytica A1 leukotoxin on bovine neutrophils: degranulation and generation of oxygen-derived free radicals.

Authors:  S K Maheswaran; D J Weiss; M S Kannan; E L Townsend; K R Reddy; L O Whiteley; S Srikumaran
Journal:  Vet Immunol Immunopathol       Date:  1992-06       Impact factor: 2.046

5.  Preliminary investigation of the mechanism of inhibition of bovine lymphocyte proliferation by Pasteurella haemolytica A1 leukotoxin.

Authors:  A L Majury; P E Shewen
Journal:  Vet Immunol Immunopathol       Date:  1991-08       Impact factor: 2.046

6.  Down-regulation of the surface expression of class I MHC antigens by human cytomegalovirus.

Authors:  Y Yamashita; K Shimokata; S Mizuno; H Yamaguchi; Y Nishiyama
Journal:  Virology       Date:  1993-04       Impact factor: 3.616

7.  In vitro biological activities of Escherichia coli-derived bovine interferons-alpha, -beta, and -gamma.

Authors:  C W Czarniecki; E B Hamilton; C W Fennie; R L Wolf
Journal:  J Interferon Res       Date:  1986-02

8.  Virus-induced loss of class I MHC antigens from the surface of cells infected with myxoma virus and malignant rabbit fibroma virus.

Authors:  L K Boshkov; J L Macen; G McFadden
Journal:  J Immunol       Date:  1992-02-01       Impact factor: 5.422

9.  The bovine alveolar macrophage. II. In vitro studies with Pasteurella haemolytica.

Authors:  M L Benson; R G Thomson; V E Valli
Journal:  Can J Comp Med       Date:  1978-07

10.  The effect of subunit or modified live bovine herpesvirus-1 vaccines on the efficacy of a recombinant Pasteurella haemolytica vaccine for the prevention of respiratory disease in feedlot calves.

Authors:  R J Harland; A A Potter; S van Drunen-Littel-van den Hurk; J Van Donkersgoed; M D Parker; T J Zamb; E D Janzen
Journal:  Can Vet J       Date:  1992-11       Impact factor: 1.008

View more
  3 in total

1.  Pasteurella haemolytica leukotoxin induces bovine leukocytes to undergo morphologic changes consistent with apoptosis in vitro.

Authors:  P K Stevens; C J Czuprynski
Journal:  Infect Immun       Date:  1996-07       Impact factor: 3.441

2.  Binding of Pasteurella haemolytica leukotoxin to bovine leukocytes.

Authors:  J F Brown; F Leite; C J Czuprynski
Journal:  Infect Immun       Date:  1997-09       Impact factor: 3.441

3.  Characterization of the hemolytic activity of Haemophilus ducreyi.

Authors:  P A Totten; D V Norn; W E Stamm
Journal:  Infect Immun       Date:  1995-11       Impact factor: 3.441

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.